Who invested in Valneva

3 rounds we have observed, with the 8 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 7 months ago

Funding summaryUpdated 26 Oct 2026

$310Mraised across 3 rounds since 2013, from 3 sources

$52MVenture$215MDebt$43MRound

Latest round: Round, $43MApr 2026
Biggest round: $215MDebt · Oct 2025
Investors: 8

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2013201520172019202120232025

$52MVenture$215MDebt$43MRound

First round: Venture, $52M
Biggest round: $215M
Usual gap between rounds: 12.3 years

The rounds

Apr 2026
Round$43M4 new1 returning
Source recorded
Oct 2025
Debt$215M4 new
Source recorded
Jun 2013
Venture$52M
No investor was named in the report.
Reported by eurobiotechnews.eu

Founders and team

From Valneva's own website: 4 on the team.

Dipal PatelChief Commercial Officer
Peter BühlerChief Financial Officer
Petra PesendorferChief People Officer
Vincent DequenneChief Operating Officer

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Venture2013Debt2025Round2026

Cormorant Asset Management

Vivo Capital

TCG

TCG Crossover

Everyone who backed them

BpifranceGovernment2rounds

OrbiMedPrivate equity1round

Scottish EnterpriseGovernment1round

DeerfieldVC firm1round

Cormorant Asset ManagementPrivate equity1round

Vivo CapitalPrivate equity1round

TCGPrivate equity1round

TCG CrossoverVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Valneva as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.